As a mid-sized global biopharmaceutical company, Ipsen improves patients’ lives through research, innovation and the development of transformative medicines in Oncology, Rare Disease and Neuroscience.



Improving people’s lives and health outcomes by focusing on areas of high unmet medical need, we are accelerating our momentum and rapidly boosting our pipeline to bring the full potential of our innovative medicines to patients.

Author Image

Our strategy has been instrumental in making us a leader in our field. Our global presence, resources, expertise and strong track record commercializing our medicines are resulting in a real impact for people living with high unmet medical needs. We’re leveraging the full force of Ipsen’s infrastructure, innovation and passion to develop new therapies and valuable collaborations.

David Loew




Putting patients at the heart of our work

Our commitment to improving the lives and medical outcomes of patients is the driving force behind every decision made at Ipsen. We believe in working with patients, for patients, listening to their needs and involving their insights in the entire.



Shaping a more sustainable future

Ipsen is dedicated to safeguarding and preserving our planet. The Generation Ipsen ESG responsibility strategy lays out ambitious goals for the company in each of four pillars: Environment, Patients, People and Governance.

Careers at Ipsen

Ipsen offers a multitude of exciting opportunities for talented and motivated people in careers ranging from medial and clinical research to sales, marketing, finance, IT, HR and legal services. We are committed to providing our employees with a workplace that is welcoming, challenging and inclusive.

Top Ipsen stories

29 February 2024 2 mins read

Working together to create positive change in rare diseases

Every four years, Rare Disease Day lands on the ‘rarest’ day of the year, 29th February. Due to leap years, this day is normally celebrated on 28th February, but this year means it is taking place on its intended day….

12 February 2024 2 mins read

The not-so-rare challenges of rare liver diseases

Hearing a rare liver disease diagnosis can be one of the most emotionally turbulent moments in a person’s life.1 For the parents of the estimated 1 in 50,000 – 100,000 newborns impacted by rare liver diseases, this moment is all…

09 February 2024 5 mins read

Navigating STEM Careers: Shared Wisdom from Inspiring Women at Ipsen

11th February marks International Day of Women and Girls in Science. To celebrate the occasion, we spoke to Martine Zimmermann, Jill Buck, Alison Mason, Florence Meyer-Losic, and Christelle Huguet to hear the advice they would share with their younger selves…

08 February 2024 1 mins read

Ipsen delivers FY 2023 results and anticipates four launches in 2024

Hear what Ipsen CEO David Loew has to say about our solid full-year results and a new era of dynamic growth.

08 February 2024 0 mins read

FY 2023 results announcement 

Ipsen’s FY 2023 results announcement took place on 8 February 2024 at 7am CET/1am EST.

02 February 2024 3 mins read

Caring for a Loved One with Metastatic Pancreatic Cancer: Nora’s Story

Nora and her husband, Hector, met 39 years ago, got married shortly after, and have been inseparable ever since. In 2021, Hector was diagnosed with metastatic pancreatic cancer, which threw their entire family into navigating a very difficult diagnosis. Nora…

31 January 2024 1 mins read

Continuously improving how we engage with patient communities 2023 Ipsen patient organization engagement satisfaction survey results  

In 2023 Ipsen launched its third global patient organization engagement survey, featuring the perspectives of 85 patient organizations (POs) globally. These findings will be used to help Ipsen deliver on what matters most to patients and caregivers. For the third…

21 December 2023 2 mins read

J.P. Morgan 2024: Ipsen discusses progress, next phase of growth and partnering ambition

At the J.P. Morgan Healthcare Conference in San Francisco from January 8 to 11, 2024,  Ipsen’s management team leaders will discuss our transformation story, next phase of growth and external innovation ambitions.

12 December 2023 3 mins read

Uniting for patients: Ipsen’s first patient centricity week – Care 2 Know More

At Ipsen, improving patients’ lives drives us. We work together with patients, for patients. However, we know that understanding how to be more patient centric can be challenging, especially if you don’t work with patients in your day-to-day role.

29 November 2023 1 mins read

‘Get men talking’: breaking the silence around prostate cancer

Tim Batchelor, Ipsen’s Head of Global Commercial Learning & Development, candidly shares his experience of living with prostate cancer. At the age of 48, Tim was confronted with a prostate cancer diagnosis. His early detection proved pivotal, leading to successful…